ReviewPharmaceuticals (Basel, Switzerland)2021

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.

Julie Bolcaen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.